Viewing nowCombinationRosuemjet Tablet 10/10 mg (Ezetimibe, Rosuvastatin)
Ezetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202004140 · Approved 2020.05.29 · Insurance code 622804330
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This drug helps reduce high total cholesterol and LDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing the good cholesterol, HDL cholesterol. In particular, this drug is used in conjunction with dietary therapy, as a supplementary treatment when dietary control limiting saturated fat and cholesterol intake is insufficient. It is used in patients at high risk of atherosclerotic vascular disease due to hypercholesterolemia, and it is important to first identify and treat secondary causes such as diabetes or hypothyroidism depending on the patient's condition. Regular checks of lipid levels are necessary, and if triglycerides are very high, accurate LDL cholesterol levels should be measured through ultracentrifugation. Lipid tests should also be quickly conducted in cases of acute coronary events to establish appropriate treatment plans. Overall, this drug is used effectively to improve dyslipidemic conditions.
This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.
This drug can cause a rare side effect called rhabdomyolysis, which can lead to serious problems with muscles. Since it may rapidly worsen kidney function, patients should stop taking the drug immediately and consult a doctor if they experience severe muscle pain or weakness. Patients should undergo liver function tests before taking this drug, and it should not be administered if there are abnormal symptoms or persistently high liver enzyme levels. Regular liver function tests should be conducted if liver abnormalities are suspected, and the medication should be stopped if liver enzymes rise significantly. Patients consuming large amounts of alcohol or with a history of liver disease, those with severe kidney dysfunction, and patients with muscle disorders should take this drug with caution. In particular, patients with poor kidney function or hypothyroidism are at higher risk of muscle problems and should be monitored closely. This drug should not be given to pregnant or potentially pregnant women, or nursing mothers, and women of childbearing age should ensure appropriate contraception while taking it. During treatment, if symptoms such as muscle pain, cramping, weakness, or fever arise, immediate medical attention should be sought and blood tests conducted to assess for muscle damage if necessary. There may be interactions with other medications, so all current medications should be disclosed to healthcare professionals, especially when taken with cyclosporine, fibric acid derivatives, certain antifungals, and antivirals. Symptoms such as dizziness or headache may occur, so caution is advised during driving or operating machinery. This drug is generally not recommended for children as safety and efficacy have not been established. In case of overdose, there is no specific antidote available; treatment should be symptomatic and supportive, and liver function and muscle damage should be closely monitored. This drug contains lactose, so it should not be given to patients with lactose intolerance, and it should be discontinued immediately if serious skin reactions occur.
nasopharyngitis, joint pain, headache, increase in ALT, increase in AST, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, unusual feeling, drug intolerance, colonic polyp, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, positional dizziness, migraine, diabetes, glucose load disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, cellulitis, hepatic steatosis, liver dysfunction, liver toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, clammy sweat, dermatitis, burning sensation of the skin, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory difficulty, pelvic pain, breast cysts, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, rhabdomyolysis, weakness, fatigue, numbness, paraesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, cough, shortness of breath, diarrhea, thrombocytopenia, jaundice, hepatitis, cholelithiasis, cholecystitis, anaphylaxis, urticaria, rash, vascular edema, erythema multiforme, joint pain, myalgia, increase in creatine phosphokinase, myopathy, increase in liver aminotransferases, hepatitis, nausea, tremor, diabetic neuropathy, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastrium, belching, gastrointestinal disorder, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, liver dysfunction, increased blood creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to protect it from air and moisture, and storage temperatures should be maintained between 1 to 30 degrees Celsius. Proper storage will maintain the drug's efficacy for a longer time.
Pale pink, oblong film-coated tablet
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Hyundai Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication · Combination
Boryung Co., Ltd.
CombinationRosuvastatin Calcium Micronized 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium Micronized 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.